Targeting dysregulated CB1 receptors in a Down syndrome mouse model improves neurological outcomes. [PDF]
Vázquez-Oliver A +8 more
europepmc +1 more source
Anti-inflammatory and analgesic potential of minor cannabinoids in vivo. [PDF]
Vanegas SO +4 more
europepmc +1 more source
Pharmacokinetic and pharmacodynamic properties of cannabigerol in male mice. [PDF]
Mabou Tagne A +10 more
europepmc +1 more source
Rimonabant: una nueva perspectiva en el tratamiento de las conductas adictivas
Se revisa la farmacología, eficacia clínica, farmacocinética, seguridad y lugar en la terapéutica de rimonabant, un nuevo antagonista selectivo de los receptores cannabinoides CB1.Se realizó una revisión de la literatura primaria obtenida en el MEDLINE ...
Bellver, Maria +3 more
core
Quinacrine and rimonabant prolong the life span of Caenorhabditis elegans. [PDF]
He Q +5 more
europepmc +1 more source
Modulatory Effects of CB1 Receptors on Cognitive Performance in Rat Model of Empathic Pain. [PDF]
Rahimi Shourmasti F +5 more
europepmc +1 more source
Topical WIN 55 212-2 Confers Long-Term Intraocular Pressure-Independent Neuroprotection in the DBA/2J Mouse Model of Glaucoma. [PDF]
Gallo Afflitto G +8 more
europepmc +1 more source
Pharmacotherapy for Cannabis Use Disorder: Preclinical and Clinical Models. [PDF]
Bedillion MF +5 more
europepmc +1 more source
Diet-dependent modulation of energy balance by CB1 signaling in peripheral sensory neurons. [PDF]
Linden B +15 more
europepmc +1 more source
Brain Hsp90 Inhibition Mitigates Facial Allodynia in a Rat Model of CSD Headache and Upregulates Endocannabinoid Signaling in the PAG. [PDF]
Palomino SM +5 more
europepmc +1 more source

